Zymeworks Chief Scientific Officer Paul Andrew Moore sells $1.04 million in common shares
ZYME•Paul Andrew Moore sold 39,741 Zymeworks common shares on Nov. 13, 2026, for about $1.04 million, and exercised options for 25,000 shares at $5.82 each.
1. Share transactions
Moore sold 7,367 shares at $26.14, 7,374 at $26.09 and 25,000 at $26.04. After the transactions, he directly held 33,756 common shares and 175,000 stock options.




